Compare Enveric Biosciences Inc (ENVB) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Occidental Petroleum Corporation — how do they compare? Enveric Biosciences Inc trades at $1.36 (market cap $5.32M), while Occidental Petroleum Corporation trades at $53.73 (market cap $53.48B). The key difference: Occidental Petroleum Corporation is far larger — about 10052.6× Enveric Biosciences Inc's market cap, and Occidental Petroleum Corporation pays a 1.93% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | OXY | |
|---|---|---|
Market Cap | $5.32M | $53.48B |
Sector | Health | Energy |
52-Week High | $17.40 | $66.24 |
52-Week Low | $1.28 | $38.92 |
Enterprise Value | $408.82K | $74.57B |
Dividend Yield | — | 1.93% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Occidental Petroleum (OXY) trades at $54.57, down 0.44% on the day, with a bullish technical outlook supported by moving averages. The stock has consistently beaten earnings estimates in recent quarters, including Q1 2026 EPS of $1.06 versus $0.601 expected. Revenue declined to $21.59B in 2025, but net income margin remains healthy at 22.42%. Recent news highlights an Evercore upgrade and rising oil prices due to Middle East disruptions.
OXY offers upside to the $66.14 consensus price target, driven by debt reduction, production growth, and exposure to higher oil prices. Risks include volatile energy markets, execution challenges under new CEO Richard Jackson, and premium valuation with a P/E of 72.66. Institutional sentiment is positive with 50% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
